Non-invasive Differentiation of Supraventricular Tachyarrhythmia

Recruiting Observational Study
Supraventricular Arrhythmia Atrial Fibrillation
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,250 (estimated)
Sponsor
RWTH Aachen University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

1. Questionnaire for supraventricular tachycardia: About history and targeted diagnosis of supraventricular tachycardia 2. Extended Signal-averaged ECG for detailed P-Wave analysis and to calculate a virtual atrial electrocardiogram (ECG)

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Scheduled for ablation of a supraventricular tachycardia (atrial fibrillation, typical atrial flutter, AV nodal reentry tachycardia, accessory pathway) * majority Exclusion Criteria: * Unstable patient with need for intensive medical care * Lack of language skills or limited…
Contacts

Matthias D Zink, MD

00492418035113

mzink@ukaachen.de

CONTACT

Michael Gramlich

mgramlich@ukaachen.de

CONTACT